Wyeth joins search for promising TLR drugs
February 15, 2006Research and Development
A new collaboration between Wyeth and an Irish biotech company is to investigate the potential of 'toll like receptors', which …
Reaching new heights in branding
February 15, 2006Sales and Marketing
The pharma industry has come a long way from the days when it believed that products were all about safety …
Talman and Crozier launch new PR agency
February 14, 2006Medical Communications
Two senior healthcare PR executives have launched Just:: a new agency which they say will redefine the traditional client/agency relationship.Emma …
Abbott suspended from ABPI over sleaze
February 10, 2006Sales and Marketing ethics
All expenses paid trips for doctors to see greyhound racing, visits to Wimbledon centre court and even a lap dancing …
More Tamiflu released for UK areas hit by seasonal flu
February 10, 2006Sales and Marketing
Extra supplies of anti-viral treatment Tamiflu are to be made available in areas of the UK suffering from high levels …
GSK looks ahead to surge of products in 2006
February 10, 2006Sales and Marketing
GlaxoSmithKline has unveiled strong growth in sales and earnings in 2005, and is preparing for a series of key filings, …
GSK’s research chief leaves for Gates Foundation
February 9, 2006Research and Development
GlaxoSmithKline's head of research and development Tachi Yamada is to leave the company, having been recruited by Bill Gates to …
Doctors warn on new medical assistant proposals
February 9, 2006Doctors have warned that patients may be confused by new non-medically trained assistants, who the government want to carry out …
Pfizer considers sale of OTC division
February 8, 2006Sales and Marketing
Pfizer says it is considering selling off its consumer medicines division as part of a new drive to improve flagging …
Big drop in animal rights attacks
January 31, 2006Sales and Marketing
The number of attacks by animal rights extremists saw a significant fall in 2005, with new laws introduced during the …
Europe approves first ever biotech generic
January 30, 2006Sales and Marketing
Europe's medicines regulator has approved Sandoz's Omnitrope, the world's first generic equivalent or 'biosimilar' of an existing biotech drug.Patents on …
Merck battling more lawsuits over Vioxx
January 27, 2006Sales and Marketing
Merck says that it will conduct a vigorous defence in the lawsuit brought by the family of Leonel Garza, who …
‘Break even culture’ must end, Hewitt tells NHS
January 27, 2006Health secretary Patricia Hewitt has unveiled the strategic and financial framework for the NHS in 2006/7, re-stating the government's pledge …
Humira becomes Britain’s first biotech blockbuster
January 26, 2006Research and Development
The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …
Eisai invests
January 26, 2006Manufacturing and Production
Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …
Amgen to expand R&D investment in UK
January 26, 2006Research and Development
Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …
Helping marketers to break ranks
January 26, 2006Business Services
In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …
Limited access to Alzheimer’s drugs leaves patients groups dissatisfied
January 25, 2006Sales and Marketing
Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …
Roche and biotech swap roles in novel collaboration
January 24, 2006Research and Development
Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …
Mergers will create gulf between GPs and PCTs
January 20, 2006Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
